BPG is committed to discovery and dissemination of knowledge
Featured Articles
8/24/2017 8:52:28 AM | Browse: 705 | Download: 2175
 |
Received |
|
2017-01-12 08:56 |
 |
Peer-Review Started |
|
2017-01-16 08:39 |
 |
First Decision by Editorial Office Director |
|
|
 |
Return for Revision |
|
2017-04-17 15:27 |
 |
Revised |
|
2017-06-22 15:27 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2017-07-18 09:28 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2017-07-24 05:07 |
 |
Articles in Press |
|
2017-07-24 05:07 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2017-08-18 07:57 |
 |
Publish the Manuscript Online |
|
2017-08-24 04:57 |
| ISSN |
1949-8462 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Cardiac & Cardiovascular Systems |
| Manuscript Type |
Basic Study |
| Article Title |
Interleukin-19 is cardioprotective in dominant negative cyclic adenosine monophosphate response-element binding protein-mediated heart failure in a sex-specific manner
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Danielle R Bruns, Alexander R Ghincea, Christian V Ghincea, Yasu-Taka Azuma, Peter A Watson, Michael V Autieri and Lori A Walker |
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| University of Colorado-Denver Center for Women’s Health Research |
To Walker LA |
| NIH NHLBI |
HL007822-19 (to Bruns DR) |
| NIH NHLBI |
HL117724 (to Autieri MV) |
| NIH NHLBI |
HL115575 (to Autieri MV) |
|
| Corresponding Author |
Lori A Walker, PhD, Division of Cardiology, Department of Medicine, University of Colorado-Denver, 12700 E. 19th Ave, Aurora, CO 80045, United States. lori.walker@ucdenver.edu |
| Key Words |
Cardiac dysfunction; Sex differences; Heart failure; Interleukin-19 |
| Core Tip |
Heart failure (HF) is a sexually dimorphic disease. In a female-dominant model of HF, the do-minant negative cyclic AMP response-element binding protein (dnCREB) mouse, female mice show accelerated cardiac morbidity and mortality alongside downregulated interleukin-19 (IL-19) expression, while male mice maintain IL-19 expression and are protected against cardiac dysfunction. We generated a novel double transgenic mouse with dnCREB and IL-19 knockout to test the hypothesis that IL-19 is cardioprotective. We show accelerated cardiac morbidity only in male mice, supporting the hypothesis that IL-19 is a sex-specific cardioprotective cytokine. |
| Publish Date |
2017-08-24 04:57 |
| Citation |
Bruns DR, Ghincea AR, Ghincea CV, Azuma YT, Watson PA, Autieri MV, Walker LA. Interleukin-19 is cardioprotective in dominant negative cyclic adenosine monophosphate response-element binding protein-mediated heart failure in a sex-specific manner. World J Cardiol 2017; 9(8): 673-684
|
| URL |
http://www.wjgnet.com/1949-8462/full/v9/i8/673.htm |
| DOI |
http://dx.doi.org/10.4330/wjc.v9.i8.673 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.